Risk factor
Fair trading liquidity
Profitability factor
Very low or no dividends
About
Luoxin Pharmaceuticals Group Stock Co., Ltd. is a Chinese pharmaceutical enterprise, primarily focused on the research, development, manufacture, and commercialization of pharmaceutical products. Headquartered in Linyi, the company offers an extensive portfolio of active pharmaceutical ingredients (APIs) and intermediates. These key components cater to a wide array of therapeutic areas, including antiviral and anti-infective treatments, respiratory and digestive system disorders, nervous and endocrine system conditions, cardiovascular health, oncology, and anti-allergy medications. Additionally, it supplies APIs and intermediates for antipyretic, analgesic, and anti-inflammatory drugs. Beyond its core pharmaceutical activities, Luoxin Pharmaceuticals also ventures into the provision of medical treatment and broader health services. The company adopted its current name, Luoxin Pharmaceuticals Group Stock Co., Ltd., in April 2020, having previously operated as Zhejiang Doyin Pump Industry Co., Ltd.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is trading at neutral levels on P/FCF.